Virbac acquiert Sasaeah, un acteur majeur de la santé animale au Japon
April 02, 2024 11:45 ET
|
Virbac
Le 1er avril, nous avons finalisé avec succès l'acquisition de Sasaeah. Cette acquisition stratégique apportera à Virbac une position de leader sur le marché des vaccins pour animaux d’élevage au...
Virbac acquired Sasaeah, a leading animal health player in Japan
April 02, 2024 11:45 ET
|
Virbac
On April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle...
Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2023
March 19, 2024 13:00 ET
|
Virbac
Communiqué de mise à disposition des comptes consolidés au 31 décembre 2023. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2023 sur le site internet du...
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023
March 19, 2024 13:00 ET
|
Virbac
Public release of Virbac Consolidated Accounts at 31 December 2023. The Group released its 2023 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com,...
Virbac : Résultats annuels 2023
March 19, 2024 12:45 ET
|
Virbac
Chiffre d’affaires en progression de 4,9% permettant des gains de parts de marché malgré des difficultés en 2023 Rentabilité opérationnelle1 2023 à un niveau historique de 23,2% du chiffre d’affaires ...
VIRBAC: 2023 ANNUAL RESULTS
March 19, 2024 12:45 ET
|
Virbac
Revenue up 4.9%, enabling market share gains despite difficulties in 20232023 operating profitability1 at an all-time high of 23.2% of revenue Up 0.4 points compared to 2022 Strong momentum...
Global Swine Vaccines Market Size To Worth USD 2.5 Billion By 2033 | CAGR of 5.24%
March 18, 2024 07:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, March 18, 2024 (GLOBE NEWSWIRE) -- The Global Swine Vaccines Market Size is Expected to Grow from USD 1.5 Billion in 2023 to USD 2.5 Billion by 2033, at a Compound Annual...
Global Veterinary Vaccine Market 10 Year Analysis and Forecast 2023-2033, Featuring Key Player Profiles for Ceva Sante Animale, Elanco Animal Health, Merck, Zoetis, Phibro Animal Health and Virbac
March 15, 2024 14:13 ET
|
Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Vaccine Market - A Global and Regional Analysis: Focus on Type, Disease, Technology, Route of Administration, Distribution Channel, and...
Global Animal Biotechnology Market to Reach $45.70 Billion by 2030 Owing To Growing Demand for Genetically Modified Animals | Says Coherent Market Insights
March 12, 2024 06:31 ET
|
CMI
Burlingame, March 12, 2024 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, Global Animal Biotechnology Market, By Product Type (Diagnostics Tests, Vaccines, Drugs,...
Virbac : Declaration of the number of shares and voting rights 02/2024
March 11, 2024 06:03 ET
|
Virbac
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the...